CADE uses its call-in powers to review transactions in digital markets and address new forms of concentration

On 12 May 2026, at the 265th Judgment Session of the Administrative Council for Economic Defense (CADE), the Brazilian antitrust authority took a significant step regarding transactions involving the digital markets. On that occasion, the Tribunal analyzed five gun jumping investigations, i.e., administrative proceedings initiated to investigate transactions that had not been previously filed to […]

Government Updates the Regulation of the Brazilian Civil Rights Framework for the Internet and Expands the Obligations of Digital Platforms

On May 20, 2026, Decree No. 12,975/2026 (“Decree”) was enacted, updating the regulation of the Brazilian Civil Rights Framework for the Internet (Law No. 12,965/2014). The Decree aligns with the understandings established by the Brazilian Supreme Federal Court (“STF”) in 2025 regarding the liability of internet connection and application providers and expands obligations related to […]

Labor Court imposes fine for prompt injection in court filing

The use of artificial intelligence in the legal context has entered a new chapter following a decision issued by the 3rd Labor Court of Parauapebas, in the State of Pará, in a labor claim in which the insertion of a hidden instruction in a court filing was identified. When processing the document through Galileu, an […]

Acquisitions by funds: CADE reinforces its approach to economic groups

On April 8, 2026, the Tribunal of the Administrative Council for Economic Defense (“CADE”) unanimously ruled that the joint acquisition by the Quíron and Tessália FIPs1 (under the control of Master Group) of an 11.97% stake in Oncoclínicas constituted premature consummation — known as gun jumping — and ordered its mandatory notification. Initially, the Quíron […]

AI in Healthcare: Applications, Risks, and Regulatory Compliance

Artificial Intelligence is reshaping the healthcare sector, bringing with it opportunities, risks, and an increasingly demanding regulatory landscape. Our Technology and Innovation team has prepared a report analyzing the main applications of AI in medicine, the legal risks involved, and the obligations set forth in the LGPD, Anvisa RDC No. 751/2022, CFM Resolution No. 2,454/2026, […]

Contact
Press & Media inquiries
Helena Pawlow
(+55) 11 97310-8569
Anderson
(+55) 51 99539 1212